Furthermore, IDO1 can be induced in endothelial cells, CAFs, and MSCs, which could participate in mediating an immunosuppressive TME, for instance, supporting cancer cells to evade tumor dormancy (95), impairing NK cell function (96), and inducing Treg expansion (28). Here, IDO1 is linked to cancer.